{"resourceType":"Observation","id":"0a1f7f55-fd4b-5b39-bef4-c7270eb02615","meta":{"versionId":"1","lastUpdated":"2022-05-24T16:08:57.901-04:00","source":"#0Z8SPEwjRiEzQGsT","profile":["http://fhir.mimic.mit.edu/StructureDefinition/mimic-observation-micro-test"]},"identifier":[{"system":"http://fhir.mimic.mit.edu/identifier/observation-micro-test","value":"8313610-90134"}],"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"laboratory"}]}],"code":{"coding":[{"system":"http://fhir.mimic.mit.edu/CodeSystem/microbiology-test","code":"90134","display":"EPSTEIN-BARR VIRUS VCA-IgM AB"}]},"subject":{"reference":"Patient/73fb53d8-f1fa-53cd-a25c-2314caccbb99"},"encounter":{"reference":"Encounter/f5cd04ba-2d1a-5601-82a5-1fb9b784fd58"},"effectiveDateTime":"2146-06-12T04:30:00-04:00","valueString":"NEGATIVE <1:10 BY IFA.  INTERPRETATION: RESULTS INDICATIVE OF PAST EBV INFECTION.  In most populations, 90% of adults have been infected at sometime with EBV and will have measurable VCA IgG and EBNA antibodies. Antibodies to EBNA develop 6-8 weeks after primary infection and remain present for life. Presence of VCA IgM antibodies indicates recent primary infection.  ","specimen":{"reference":"Specimen/2a3953a2-281d-5bfc-bd5b-03ecaa15ba61"}}